Lin Shui
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
- Oncology 6
- Pancreatic and Hepatic Oncology Research 3
- Cancer Immunotherapy and Biomarkers 2
- Lymphatic System and Diseases 1
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Yi Cheng (6 shared papers)Hong Zhu (3 shared papers)Xi Yang (2 shared papers)Jian Li (1 shared paper)Qin Sun (1 shared paper)Haoyu Ren (1 shared paper)Xiaohan Zhou (2 shared papers)Wanting Hou (1 shared paper)
In The Last Decade
Lin Shui
15 papers receiving 418 citations
Peers
Comparison fields: 5 of 54
- Oncology 137
- Health Informatics 11
- Radiology, Nuclear Medicine and Imaging 87
- Genetics 18
- Cancer Research 27
Countries citing papers authored by Lin Shui
This map shows the geographic impact of Lin Shui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shui more than expected).
Fields of papers citing papers by Lin Shui
This network shows the impact of papers produced by Lin Shui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shui. The network helps show where Lin Shui may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Shui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 119 | |
| 2 | 2020 | 103 | |
| 3 | 2021 | 35 | |
| 4 | 2022 | 35 | |
| 5 | 2019 | 33 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 11 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 5 | |
| 13 | Relationship between cyclooxygenase-2 (COX-2) content and prognosis in nasopharyngeal carcinoma before and after radiochemotherapy. | 2021 | 4 |
| 14 | 2020 | 3 | |
| 15 | 2020 | 1 | |
| 16 | Effect of ecdystrone on proliferation of human umbilical vein endothelial cells | 1997 | 0 |
About Lin Shui
Lin Shui is a scholar working on Oncology, Cancer Research, Otorhinolaryngology, Biotechnology and Genetics, having authored 16 papers that have together received 423 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Breast Cancer Treatment Studies (2 papers), Lymphatic System and Diseases (1 paper), Epigenetics and DNA Methylation (1 paper), Pharmacological Effects and Assays (1 paper), Glioma Diagnosis and Treatment (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Oncology (137 citations), Health Informatics (11 citations), Radiology, Nuclear Medicine and Imaging (87 citations), Genetics (18 citations) and Cancer Research (27 citations). Lin Shui has collaborated with scholars based in China, Germany and Burundi. Frequent co-authors include Yi Cheng, Hong Zhu, Xi Yang, Jian Li, Qin Sun, Jian Li, Haoyu Ren, Xiaohan Zhou, Wanting Hou and Ling Gao. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Molecular Cancer, BMC Cancer and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.